PRESS RELEASE published on 05/12/2026 at 22:30, 1 month 9 days ago DBV Technologies participera à la 4e édition de la conférence annuelle BioConnect Investor organisée par H.C. Wainwright au Nasdaq DBV Technologies participera à la 4e édition de la conférence BioConnect Investor au Nasdaq avec Daniel Tassé pour discuter de l'immunothérapie épicutanée (EPIT) pour les allergies alimentaires Nasdaq DBV Technologies Allergies Alimentaires BioConnect Investor Immunothérapie Épicutanée (EPIT)
PRESS RELEASE published on 05/12/2026 at 22:30, 1 month 9 days ago DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq DBV Technologies to participate in H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq. Presentation by CEO Daniel Tassé on May 19, 2026, at 9:00 am ET Nasdaq H.C. Wainwright DBV Technologies Food Allergies BioConnect Investor Conference
BRIEF published on 04/02/2026 at 22:35, 2 months 19 days ago DBV Technologies Reports Voting Rights and Shares as of March 31, 2026 Voting Rights Shares DBV Technologies NYSE Euronext Paris March 2026
BRIEF published on 04/02/2026 at 22:35, 2 months 19 days ago DBV Technologies : Informations sur le Capital Social au 31 Mars 2026 Marché Financier Droits De Vote Capital Social DBV Technologies Information Légale
BRIEF published on 04/02/2026 at 22:35, 2 months 19 days ago DBV Technologies: Share Capital Information as of March 31, 2026 Share Capital Voting Rights Financial Market DBV Technologies Legal Information
BRIEF published on 04/02/2026 at 22:35, 2 months 19 days ago DBV Technologies publie ses droits de vote et son nombre d'actions au 31 mars 2026 Actions Droit De Vote NYSE Euronext Paris Technologies DBV Mars 2026
PRESS RELEASE published on 04/02/2026 at 22:30, 2 months 19 days ago Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 Press release on the total number of voting rights and shares of the company as of March 31, 2026, in compliance with Article 223-16 of the General Regulations of the Autorité des Marchés Financiers Voting Rights Shares Financial Markets Regulations NYSE Euronext Paris
PRESS RELEASE published on 04/02/2026 at 22:30, 2 months 19 days ago Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2026 Résumé du nombre total d'actions et de droits de vote au 31 mars 2026 pour NYSE Euronext Paris, Code ISIN FR0010417345 Droits De Vote Capital Social Actions NYSE Euronext Paris 31 Mars 2026
BRIEF published on 04/02/2026 at 10:01, 2 months 19 days ago DBV Technologies : Franchissement de seuils de MPM BioImpact LLC Droits De Vote Actions Franchissement De Seuils DBV Technologies MPM BioImpact LLC
BRIEF published on 04/02/2026 at 10:01, 2 months 19 days ago DBV Technologies: MPM BioImpact LLC Threshold Crossing Voting Rights Actions Crossing Thresholds DBV Technologies MPM BioImpact LLC
Published on 06/20/2026 at 01:00, 2 days 1 hour ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 2 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 21 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 3 days ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 1 day 4 hours ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 20 hours ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 2 days 5 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 2 days 5 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 2 days 7 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 2 days 6 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 6 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 6 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 6 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026